|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Ms C Thomas
|
|
|
b)
|
Position/status
|
SVP, HR
|
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of
the
financial
instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of
the
transaction
|
Acquisition of Ordinary Shares following the re-investment of
dividends paid to shareholders on 13 October 2016 on shares held in
the Deferred Annual Bonus Plan Post-Tax.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.0319
|
32.163
|
||
|
£17.0319
|
32.345
|
||
|
d)
|
Aggregated
information
Aggregated
volume
Price
|
n/a (single transaction)
|
|
|
e)
|
Date of
the
transaction
|
2016-10-13
|
|
|
f)
|
Place
of
the transaction
|
London Stock Exchange (XLON)
|
|